Tag: #Mircera

Introduction:Anemia is a common and challenging complication for patients with chronic kidney disease (CKD) undergoing hemodialysis. A recent study published in the Journal of Clinical Nephrology compared two erythropoiesis-stimulating agents, Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) and Epoetin Alfa (Eprex), to determine their effectiveness in maintaining hemoglobin levels. This research sheds light on the optimal treatment…